Carmen Herranz

602 total citations
7 papers, 146 citations indexed

About

Carmen Herranz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Carmen Herranz has authored 7 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Carmen Herranz's work include Tuberous Sclerosis Complex Research (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Renal cell carcinoma treatment (2 papers). Carmen Herranz is often cited by papers focused on Tuberous Sclerosis Complex Research (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Renal cell carcinoma treatment (2 papers). Carmen Herranz collaborates with scholars based in Spain, Netherlands and Italy. Carmen Herranz's co-authors include Catríona M. Dowling, Patrick A. Kiely, Miguel Ángel Pujana, Marta R. Hidalgo, Alicia Amadoz, Francesca Mateo, Cankut Çubuk, José Carbonell‐Caballero, Joaquı́n Dopazo and Kinza Rian and has published in prestigious journals such as Cancer Research, Cancers and European Journal of Epidemiology.

In The Last Decade

Carmen Herranz

7 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Herranz Spain	5	76	31	26	20	18	7	146
Yuchen Du United States	6	62 0.8×	19 0.6×	43 1.7×	13 0.7×	13 0.7×	14	130
Mariya Mardamshina Israel	4	56 0.7×	28 0.9×	15 0.6×	7 0.3×	10 0.6×	5	109
Andrew Barthorpe United Kingdom	3	147 1.9×	57 1.8×	67 2.6×	31 1.6×	16 0.9×	3	213
Michael S. Nelson United States	8	73 1.0×	23 0.7×	49 1.9×	12 0.6×	15 0.8×	18	159
Charlotte Beaver United Kingdom	6	184 2.4×	34 1.1×	60 2.3×	21 1.1×	13 0.7×	7	281
Johanna I. Englund Finland	7	99 1.3×	33 1.1×	48 1.8×	11 0.6×	13 0.7×	12	188
Yinghong Yang China	7	105 1.4×	45 1.5×	36 1.4×	24 1.2×	88 4.9×	24	243
László Steiner Hungary	10	118 1.6×	20 0.6×	29 1.1×	10 0.5×	5 0.3×	15	197
Peter D.A. Shepherd United States	6	131 1.7×	32 1.0×	86 3.3×	7 0.3×	37 2.1×	19	183
Ravian L. van Ineveld Netherlands	5	115 1.5×	28 0.9×	48 1.8×	35 1.8×	10 0.6×	9	181

Countries citing papers authored by Carmen Herranz

Since Specialization

Citations

This map shows the geographic impact of Carmen Herranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Herranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Herranz more than expected).

Fields of papers citing papers by Carmen Herranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Herranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Herranz. The network helps show where Carmen Herranz may publish in the future.

Co-authorship network of co-authors of Carmen Herranz

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Herranz. A scholar is included among the top collaborators of Carmen Herranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Herranz. Carmen Herranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Herranz, Carmen, Vanesa Vicens‐Zygmunt, Antonio Román, et al.. (2020). Design of phase II, randomized, placebo-controlled study of loratadine associate with rapamycin in patients with lymphangioleiomyomatosis (LAM). 3401–3401. 1 indexed citations

2.

Palomero, Luís, Lubomir Bodnar, Francesca Mateo, et al.. (2020). EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma. Cancers. 12(2). 300–300. 9 indexed citations

3.

Çubuk, Cankut, Marta R. Hidalgo, Alicia Amadoz, et al.. (2019). Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. npj Systems Biology and Applications. 5(1). 7–7. 29 indexed citations

4.

Núñez, Olivier, Bruno Guedes Baldi, Elżbieta Radzikowska, et al.. (2019). Risk of breast cancer in patients with lymphangioleiomyomatosis. Cancer Epidemiology. 61. 154–156. 3 indexed citations

5.

Çubuk, Cankut, Marta R. Hidalgo, Alicia Amadoz, et al.. (2018). Gene Expression Integration into Pathway Modules Reveals a Pan-Cancer Metabolic Landscape. Cancer Research. 78(21). 6059–6072. 29 indexed citations

6.

Dowling, Catríona M., Carmen Herranz, & Patrick A. Kiely. (2014). Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Bioscience Reports. 34(4). 71 indexed citations

7.

Corella, Dolores, et al.. (2000). Cancer mortality and exposure to chemical carcinogens in the work place: An ecological study in the Valencian Community, Spain (1981–1995). European Journal of Epidemiology. 16(5). 401–409. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact